R. M. Karp

ScholarGPS® ID: 62004808364436

Affiliation

Praecis Pharmaceuticals, Inc.

Affiliation History

Field

Pharmacy and Pharmaceutical Sciences

Discipline

Pharmacology and Toxicology

Metrics Summary

Publication Count

Predicted Citations

Predicted h-index

Ranking

Publications and Citation History

Add Delete
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis (journal article) Lazarus, D. D. \| Doyle, E. G. \| Bernier, S. G. \| Rogers, A. B. \| Labenski, M. T. \| Wakefield, J. D. \| Karp, R. M. \| Clark, E. J. \| Lorusso, J. \| Hoyt, J. G. \| ... \| Westlin, W. F. Inflammation Research, volume 57, issue 1, pages 18-27 (2008). 10.1007/s00011-007-7075-5 Cited by (13) \| Cite \| Source
349 POSTER Effects of PPI-2458, an inhibitor of methionine aminopeptidase type-2, on growth of melanoma and expression of MITF (journal article) Hannig, G. \| Bernier, S.G. \| Karp, R.M. \| Clark, E. \| Doyle, B. \| Lorusso, J. \| Westlin, W.F. European Journal of Cancer Supplements, volume 4, issue 12, pages 109- (2006). 10.1016/S1359-6349(06)70354-8 Cite \| Source

Delete

Inflammation Research, volume 57, issue 1, pages 18-27 (2008).

European Journal of Cancer Supplements, volume 4, issue 12, pages 109- (2006).